189 related articles for article (PubMed ID: 28859868)
1. Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease.
China L; Maini A; Skene SS; Shabir Z; Sylvestre Y; Colas RA; Ly L; Becares Salles N; Belloti V; Dalli J; Gilroy DW; O'Brien A
Clin Gastroenterol Hepatol; 2018 May; 16(5):738-747.e7. PubMed ID: 28859868
[TBL] [Abstract][Full Text] [Related]
2. Administration of Albumin Solution Increases Serum Levels of Albumin in Patients With Chronic Liver Failure in a Single-Arm Feasibility Trial.
China L; Skene SS; Shabir Z; Maini A; Sylvestre Y; Bennett K; Bevan S; O'Beirne J; Forrest E; Portal J; Ryder S; Wright G; Gilroy DW; O'Brien A
Clin Gastroenterol Hepatol; 2018 May; 16(5):748-755.e6. PubMed ID: 28911947
[TBL] [Abstract][Full Text] [Related]
3. ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial.
China L; Muirhead N; Skene SS; Shabir Z; De Maeyer RP; Maini A; Gilroy DW; O'Brien AJ
BMJ Open; 2016 Jan; 6(1):e010132. PubMed ID: 26810999
[TBL] [Abstract][Full Text] [Related]
4. ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial.
China L; Skene SS; Bennett K; Shabir Z; Hamilton R; Bevan S; Chandler T; Maini AA; Becares N; Gilroy D; Forrest EH; O'Brien A
BMJ Open; 2018 Oct; 8(10):e023754. PubMed ID: 30344180
[TBL] [Abstract][Full Text] [Related]
5. Altered PGE2-EP2 is associated with an excessive immune response in HBV-related acute-on-chronic liver failure.
Wang Y; Chen C; Qi J; Wu F; Guan J; Chen Z; Zhu H
J Transl Med; 2019 Mar; 17(1):93. PubMed ID: 30890164
[TBL] [Abstract][Full Text] [Related]
6. Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway.
Maini AA; Becares N; China L; Tittanegro TH; Patel A; De Maeyer RPH; Zakeri N; Long TV; Ly L; Gilroy DW; O'Brien A
JHEP Rep; 2021 Dec; 3(6):100332. PubMed ID: 34825153
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2.
O'Brien AJ; Fullerton JN; Massey KA; Auld G; Sewell G; James S; Newson J; Karra E; Winstanley A; Alazawi W; Garcia-Martinez R; Cordoba J; Nicolaou A; Gilroy DW
Nat Med; 2014 May; 20(5):518-23. PubMed ID: 24728410
[TBL] [Abstract][Full Text] [Related]
8. Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis.
Clària J; Curto A; Moreau R; Colsch B; López-Vicario C; Lozano JJ; Aguilar F; Castelli FA; Fenaille F; Junot C; Zhang I; Vinaixa M; Yanes O; Caraceni P; Trebicka J; Fernández J; Angeli P; Jalan R; Arroyo V
J Hepatol; 2021 Nov; 75(5):1116-1127. PubMed ID: 34245803
[TBL] [Abstract][Full Text] [Related]
9. Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.
Bernsmeier C; Pop OT; Singanayagam A; Triantafyllou E; Patel VC; Weston CJ; Curbishley S; Sadiq F; Vergis N; Khamri W; Bernal W; Auzinger G; Heneghan M; Ma Y; Jassem W; Heaton ND; Adams DH; Quaglia A; Thursz MR; Wendon J; Antoniades CG
Gastroenterology; 2015 Mar; 148(3):603-615.e14. PubMed ID: 25479139
[TBL] [Abstract][Full Text] [Related]
10. Immune Regulatory Mediators in Plasma from Patients With Acute Decompensation Are Associated With 3-Month Mortality.
Becares N; Härmälä S; China L; Colas RA; Maini AA; Bennet K; Skene SS; Shabir Z; Dalli J; O'Brien A
Clin Gastroenterol Hepatol; 2020 May; 18(5):1207-1215.e6. PubMed ID: 31446184
[TBL] [Abstract][Full Text] [Related]
11. Induction of endotoxin tolerance in rat bone marrow cells by in vivo infusion of tumor necrosis factor.
Ogle CK; Guo X; Chance WT; Ogle JD
Crit Care Med; 1997 May; 25(5):827-33. PubMed ID: 9187603
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum prostaglandin E2 predicts the risk of infection in hepatitis B virus-related acute-on-chronic liver failure patients.
Huang XP; Wang Y; Chen L; Sun W; Huang Y; Xu Y; Feng TT; Luo EP; Qin AL; Zhao WF; Gan JH
Asian Pac J Trop Med; 2017 Sep; 10(9):916-920. PubMed ID: 29080622
[TBL] [Abstract][Full Text] [Related]
13. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.
Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L
Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154
[TBL] [Abstract][Full Text] [Related]
14. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.
Moreau R; Jalan R; Gines P; Pavesi M; Angeli P; Cordoba J; Durand F; Gustot T; Saliba F; Domenicali M; Gerbes A; Wendon J; Alessandria C; Laleman W; Zeuzem S; Trebicka J; Bernardi M; Arroyo V;
Gastroenterology; 2013 Jun; 144(7):1426-37, 1437.e1-9. PubMed ID: 23474284
[TBL] [Abstract][Full Text] [Related]
15. Effect of plasma exchange with albumin replacement on albumin functionality and organ dysfunction in acute-on-chronic liver failure.
Fernández J; Lozano M; Torres M; Horrillo R; Afonso N; Núñez L; Mestre A; Pérez A; Cid J; Costa M; Arroyo V; Páez A
JHEP Rep; 2024 Apr; 6(4):101017. PubMed ID: 38544553
[TBL] [Abstract][Full Text] [Related]
16. Reduced Plasma Extracellular Vesicle CD5L Content in Patients With Acute-On-Chronic Liver Failure: Interplay With Specialized Pro-Resolving Lipid Mediators.
Sánchez-Rodríguez MB; Téllez É; Casulleras M; Borràs FE; Arroyo V; Clària J; Sarrias MR
Front Immunol; 2022; 13():842996. PubMed ID: 35330909
[TBL] [Abstract][Full Text] [Related]
17. Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
Kerbert AJC; Verspaget HW; Navarro ÀA; Jalan R; Solà E; Benten D; Durand F; Ginès P; van der Reijden JJ; van Hoek B; Coenraad MJ;
Crit Care; 2017 Dec; 21(1):321. PubMed ID: 29268760
[TBL] [Abstract][Full Text] [Related]
18. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.
Clària J; Stauber RE; Coenraad MJ; Moreau R; Jalan R; Pavesi M; Amorós À; Titos E; Alcaraz-Quiles J; Oettl K; Morales-Ruiz M; Angeli P; Domenicali M; Alessandria C; Gerbes A; Wendon J; Nevens F; Trebicka J; Laleman W; Saliba F; Welzel TM; Albillos A; Gustot T; Benten D; Durand F; Ginès P; Bernardi M; Arroyo V;
Hepatology; 2016 Oct; 64(4):1249-64. PubMed ID: 27483394
[TBL] [Abstract][Full Text] [Related]
19. Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis.
China L; Becares N; Rhead C; Tittanegro T; Freemantle N; O'Brien A
Clin Transl Gastroenterol; 2022 May; 13(5):e00476. PubMed ID: 35333783
[TBL] [Abstract][Full Text] [Related]
20. Acute-on-chronic liver failure exists in patients with hepatitis B virus-related decompensated cirrhosis.
Wang SJ; Yin S; Gu WY; Zhang Y; Li H
J Dig Dis; 2018 Oct; 19(10):614-625. PubMed ID: 30226019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
